Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Equipment
Datasets
Search by expertise, name or affiliation
Anticoagulation in preterm and term neonates: Why are they special?
Rukhmi Bhat
*
, Paul Monagle
*
Corresponding author for this work
Pediatrics
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Anticoagulation in preterm and term neonates: Why are they special?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Anticoagulation
100%
Thrombosis
66%
Neonates
66%
Infant
66%
Complication
33%
Morbidity
33%
Anticoagulant Agent
33%
Epidemiology
33%
Drug
33%
Anticoagulant Therapy
33%
Pharmacodynamics
33%
Hemostatic Agent
33%
Child
33%
Pediatrics
33%
INIS
comparative evaluations
66%
populations
66%
neonates
66%
infants
66%
thrombosis
66%
epidemiology
33%
drugs
33%
risks
33%
pediatrics
33%
children
33%
management
33%
morbidity
33%
anticoagulants
33%
hemostatics
33%
Pharmacology, Toxicology and Pharmaceutical Science
Thrombosis
66%
Pharmacokinetics
33%
Complication
33%
Morbidity
33%
Anticoagulant Agent
33%
Epidemiology
33%
Hemostatic Agent
33%
Drug
33%